活性维生素D通过调节AMPK激活来改善2型糖尿病小鼠的微生物群和肠道屏障
Lewen Zhang1,2, Lijuan Zhao1, Yudie Hu1
1Center of Laboratory Animal, Suzhou Medical College of Soochow University, Suzhou, China.
Scientific reports
|December 11, 2025
概括
活性维生素D3补充剂在2型糖尿病 (T2DM) 的小鼠模型中改善了肠道微生物群平衡和肠道屏障功能. 这表明维生素D.
科学领域:
- 内分泌学和新陈代谢学
- 微生物组研究 微生物组研究
- 营养科学 营养科学
背景情况:
- 2型糖尿病 (T2DM) 的发病过程涉及复杂的相互作用,包括肠道微生物失调和炎症.
- 维生素D在T2DM中调节这些因素的作用需要进一步研究.
研究的目的:
- 在T2DM小鼠模型中研究活性维生素D3对肠道微生物群,炎症和氧化还原平衡的影响.
- 探索维生素D在改善T2DM相关的肠道失调和代谢功能障碍方面的潜力.
主要方法:
- 使用高脂肪饮食 (HFD) 和链毒素 (STZ) 建立T2DM小鼠模型.
- 用活性维生素D3 (1,25(OH) 2D3进行治疗,并评估全身和结肠的参数.
- 使用16S rRNA测序分析肠道微生物社区组成.
主要成果:
- T2DM小鼠表现出肠道微生物失调与增加的肠球菌和肠球菌,与高血糖和炎症相关.
- 维生素D3治疗恢复了肠道屏障的完整性,并减少了氧化应激和炎症标志物.
- 活性维生素D3增强了结肠AMPK酸化,这表明它在代谢信号传递中发挥了作用.
结论:
- 维生素D3的补充有效地改善了T2DM的肠道失调和相关病理.
- 维生素D-AMPK轴代表了T2DM中微生物群-代谢交叉的潜在治疗点.
- 这些发现支持维生素D在T2DM管理中的转化潜力.
关键词:
1,25 (((OH) 2D3 3D3 3D3 3D3 3D3 3D3 3D3 3D4 3D4 3D5 3D6 3D7 3D8 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9 3D9炎症 炎症是一种炎症.我们的肠道微生物群.氧化应激是一种氧化应激.这就是T2DM.相关概念视频
Role of Skin in Vitamin D Synthesis
The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.


